A detailed history of Mml Investors Services, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Mml Investors Services, LLC holds 7,199 shares of TNDM stock, worth $266,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,199
Previous 7,085 1.61%
Holding current value
$266,363
Previous $285,000 7.02%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$35.21 - $47.3 $4,013 - $5,392
114 Added 1.61%
7,199 $305,000
Q2 2024

Aug 14, 2024

SELL
$30.43 - $53.43 $17,831 - $31,309
-586 Reduced 7.64%
7,085 $285,000
Q1 2024

May 14, 2024

BUY
$22.09 - $35.41 $169,452 - $271,630
7,671 New
7,671 $272,000
Q1 2023

May 12, 2023

BUY
$35.86 - $46.5 $1,541 - $1,999
43 Added 0.84%
5,180 $210,000
Q4 2022

Feb 13, 2023

BUY
$35.49 - $56.15 $10,859 - $17,181
306 Added 6.33%
5,137 $231,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $38,815 - $61,176
887 Added 22.49%
4,831 $231,000
Q2 2022

Aug 12, 2022

BUY
$53.22 - $123.09 $67,908 - $157,062
1,276 Added 47.83%
3,944 $233,000
Q1 2022

May 13, 2022

BUY
$101.89 - $150.09 $20,479 - $30,168
201 Added 8.15%
2,668 $310,000
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $11,345 - $14,708
-96 Reduced 3.75%
2,467 $371,000
Q3 2021

Nov 15, 2021

BUY
$93.51 - $129.4 $14,120 - $19,539
151 Added 6.26%
2,563 $306,000
Q2 2021

Aug 13, 2021

BUY
$77.0 - $100.19 $185,724 - $241,658
2,412 New
2,412 $235,000
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $171,175 - $219,740
-2,106 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$86.4 - $121.75 $181,958 - $256,405
2,106 New
2,106 $202,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.